SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain

por Lens, Sabela, Miquel, Mireia, Mateos-Muñoz, Beatriz, García-Samaniego, Javier, Forns, Xavier
Publicado 2020

Strengthening vaccine confidence during the COVID-19 pandemic: A new opportunity for global hepatitis B virus elimination

por Lazarus, Jeffrey V., Picchio, Camila A., Nayagam, Shevanthi, Ratzan, Scott, Thursz, Mark
Publicado 2020

Epidemiological pattern, incidence, and outcomes of COVID-19 in liver transplant patients

por Colmenero, Jordi, Rodríguez-Perálvarez, Manuel, Salcedo, Magdalena, Arias-Milla, Ana, Muñoz-Serrano, Alejandro, Graus, Javier, Nuño, Javier, Gastaca, Mikel, Bustamante-Schneider, Javier, Cachero, Alba, Lladó, Laura, Caballero, Aránzazu, Fernández-Yunquera, Ainhoa, Loinaz, Carmelo, Fernández, Inmaculada, Fondevila, Constantino, Navasa, Miquel, Iñarrairaegui, Mercedes, Castells, Lluis, Pascual, Sonia, Ramírez, Pablo, Vinaixa, Carmen, González-Dieguez, María Luisa, González-Grande, Rocío, Hierro, Loreto, Nogueras, Flor, Otero, Alejandra, Álamo, José María, Blanco-Fernández, Gerardo, Fábrega, Emilio, García-Pajares, Fernando, Montero, José Luis, Tomé, Santiago, De la Rosa, Gloria, Pons, José Antonio
Publicado 2021

Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19”

por Iavarone, Massimo, D'Ambrosio, Roberta, Lampertico, Pietro
Publicado 2020

Impact of COVID-19 on global HCV elimination efforts

por Blach, Sarah, Kondili, Loreta A., Aghemo, Alessio, Cai, Zongzhen, Dugan, Ellen, Estes, Chris, Gamkrelidze, Ivane, Ma, Siya, Pawlotsky, Jean-Michel, Razavi-Shearer, Devin, Razavi, Homie, Waked, Imam, Zeuzem, Stefan, Craxi, Antonio
Publicado 2021

From the Editor's Desk…

por Burra, Patrizia, Tacke, Frank, Ratziu, Vlad, Zeuzem, Stefan, Sangro, Bruno, Angeli, Paolo
Publicado 2020

COVID-19 can mimic acute cholecystitis and is associated with the presence of viral RNA in the gallbladder wall

por Balaphas, Alexandre, Gkoufa, Kyriaki, Meyer, Jeremy, Peloso, Andrea, Bornand, Aurélie, McKee, Thomas A., Toso, Christian, Popeskou, Sotirios-Georgios
Publicado 2020

Health status of patients with autoimmune hepatitis is not affected by the SARS-CoV-2 outbreak in Flanders, Belgium

por Verhelst, Xavier, Somers, Nicky, Geerts, Anja, Degroote, Helena, Van Vlierberghe, Hans
Publicado 2021

From the Editor's Desk...

por Burra, Patrizia, Tacke, Frank, Ratziu, Vlad, Zeuzem, Stefan, Sangro, Bruno, Angeli, Paolo
Publicado 2020

A global investment framework for the elimination of hepatitis B

por Howell, Jessica, Pedrana, Alisa, Schroeder, Sophia E., Scott, Nick, Aufegger, Lisa, Atun, Rifat, Baptista-Leite, Ricardo, Hirnschall, Gottfried, ‘t Hoen, Ellen, Hutchinson, Sharon J., Lazarus, Jeffrey V., Olufunmilayo, Lesi, Peck, Raquel, Sharma, Manik, Sohn, Annette H., Thompson, Alexander, Thursz, Mark, Wilson, David, Hellard, Margaret
Publicado 2021

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

por Marjot, Thomas, Moon, Andrew M., Cook, Jonathan A., Abd-Elsalam, Sherief, Aloman, Costica, Armstrong, Matthew J., Pose, Elisa, Brenner, Erica J., Cargill, Tamsin, Catana, Maria-Andreea, Dhanasekaran, Renumathy, Eshraghian, Ahad, García-Juárez, Ignacio, Gill, Upkar S., Jones, Patricia D., Kennedy, James, Marshall, Aileen, Matthews, Charmaine, Mells, George, Mercer, Carolyn, Perumalswami, Ponni V., Avitabile, Emma, Qi, Xialong, Su, Feng, Ufere, Nneka N., Wong, Yu Jun, Zheng, Ming-Hua, Barnes, Eleanor, Barritt, Alfred S., Webb, Gwilym J.
Publicado 2021

COVID-19: Discovery, diagnostics and drug development

por Asselah, Tarik, Durantel, David, Pasmant, Eric, Lau, George, Schinazi, Raymond F.
Publicado 2021

SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination

por Crespo, Javier, Díaz-González, Álvaro, Iruzubieta, Paula, Llerena, Susana, Cabezas, Joaquín
Publicado 2021

From the Editor's Desk…

por Burra, Patrizia, Tacke, Frank, Ratziu, Vlad, Zeuzem, Stefan, Sangro, Bruno, Angeli, Paolo
Publicado 2020

Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points

por Fondevila, Marcos F., Mercado-Gómez, Maria, Rodríguez, Amaia, Gonzalez-Rellan, Maria J., Iruzubieta, Paula, Valentí, Víctor, Escalada, Javier, Schwaninger, Markus, Prevot, Vincent, Dieguez, Carlos, Crespo, Javier, Frühbeck, Gema, Martinez-Chantar, Maria L., Nogueiras, Ruben
Publicado 2021

Reply to: “NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues”...

por Ji, Dong, Cheng, Gregory, Lau, George
Publicado 2021

Increased expression of key SARS-CoV-2 entry points in multiple tissues in individuals with NAFLD

por Meijnikman, Abraham S., Bruin, Sjoerd, Groen, Albert K., Nieuwdorp, Max, Herrema, Hilde
Publicado 2021

Association of liver abnormalities with in-hospital mortality in patients with COVID-19

por Ding, Ze-yang, Li, Gan-xun, Chen, Lin, Shu, Chang, Song, Jia, Wang, Wei, Wang, Yu-wei, Chen, Qian, Jin, Guan-nan, Liu, Tong-tong, Liang, Jun-nan, Zhu, Peng, Zhu, Wei, Li, Yong, Zhang, Bin-hao, Feng, Huan, Zhang, Wan-guang, Yin, Zhen-yu, Yu, Wen-kui, Yang, Yang, Zhang, Hua-qiu, Tang, Zhou-ping, Wang, Hui, Hu, Jun-bo, Liu, Ji-hong, Yin, Ping, Chen, Xiao-ping, Zhang, Bixiang
Publicado 2021

Impact of the COVID-19 pandemic on HCV elimination in Spain

por Buti, Maria, Domínguez-Hernández, Raquel, Casado, Miguel Angel
Publicado 2021

Detecting HCV infection by means of mass population SARS-CoV-2 screening: A pilot experience in Northern Italy

por Giacomelli, Andrea, Pagani, Gabriele, Conti, Federico, Bassoli, Cinzia, Galli, Massimo
Publicado 2021